Clinical trial
The Contribution of Endothelin to Vasomotor Function in Diseased Coronary…
NCT00115583 · Brigham and Women's Hospital, Other · Completed
Key facts
| NCT number | NCT00115583 |
|---|---|
| Title | The Contribution of Endothelin to Vasomotor Function in Diseased Coronary Arteries |
| Official title | The Contribution of Endothelin to Vasoreactivity in Atherosclerotic Coronary Arteries |
| Lead sponsor | Brigham and Women's Hospital, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Atherosclerosis, Coronary |
| Intervention type | Drug |
| Interventions | Drug Infusion (BQ-123) |
| Enrollment | 200 |
| Start date | Nov 1, 1998 |
| Primary completion | Apr 1, 2007 |
| Completion | Apr 1, 2007 |
| First posted | Jun 24, 2005 |
| Last update posted | Dec 9, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: